本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

128.41
-3.0300-2.31%
盘后128.40-0.0100-0.01%19:45 EDT
成交量:103.04万
成交额:1.33亿
市值:128.88亿
市盈率:27.50
高:131.71
开:131.00
低:127.76
收:131.44
52周最高:160.18
52周最低:97.30
股本:1.00亿
流通股本:9,800.26万
量比:1.04
换手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):4.67
每股收益(LYR):4.67
净资产收益率:16.38%
总资产收益率:9.53%
市净率:3.96
市盈率(LYR):27.50

数据加载中...

2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities